# Seizure Treatment in Glioma

> **NCT03048084** · PHASE4 · RECRUITING · sponsor: **Leiden University Medical Center** · enrollment: 120 (estimated)

## Conditions studied

- Glioma

## Interventions

- **DRUG:** Levetiracetam
- **DRUG:** Valproic Acid

## Key facts

- **NCT ID:** NCT03048084
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-02-01
- **Primary completion:** 2026-07-01
- **Final completion:** 2028-07-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-02-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03048084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03048084, "Seizure Treatment in Glioma". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT03048084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*